These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 9220694

  • 1. Cost containment for treating hypertension in African Americans: impact of a combined ACE inhibitor-calcium channel blocker.
    Kountz DS.
    J Natl Med Assoc; 1997 Jul; 89(7):457-60. PubMed ID: 9220694
    [Abstract] [Full Text] [Related]

  • 2. Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting.
    Sapienza S, Sacco P, Floyd K, DiCesare J, Doan QD.
    Clin Ther; 2003 Jun; 25(6):1872-87. PubMed ID: 12860503
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy.
    Taylor AA, Shoheiber O.
    Congest Heart Fail; 2003 Jun; 9(6):324-32. PubMed ID: 14688505
    [Abstract] [Full Text] [Related]

  • 5. Blood pressure effects of high-dose amlodipine-benazepril combination in Black and White hypertensive patients not controlled on monotherapy.
    Chrysant SG.
    Drugs R D; 2012 Jun 01; 12(2):57-64. PubMed ID: 22571394
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Hilleman DE, Reyes AP, Wurdeman RL, Faulkner M.
    J Hum Hypertens; 2001 Aug 01; 15(8):559-65. PubMed ID: 11494095
    [Abstract] [Full Text] [Related]

  • 7. Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker.
    Okano GJ, Rascati KL, Wilson JP, Remund DD, Grabenstein JD, Brixner DI.
    Clin Ther; 1997 Aug 01; 19(6):1433-45; discussion 1424-5. PubMed ID: 9444451
    [Abstract] [Full Text] [Related]

  • 8. Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes.
    Winer N, Folker A, Murphy JA, Hung E, Bard M, Perkelvald A, Sowers JR, Bakris GL.
    Prev Cardiol; 2005 Aug 01; 8(2):87-92. PubMed ID: 15860983
    [Abstract] [Full Text] [Related]

  • 9. Racial differences in medication compliance and healthcare utilization among hypertensive Medicaid recipients: fixed-dose vs free-combination treatment.
    Dickson M, Plauschinat CA.
    Ethn Dis; 2008 Aug 01; 18(2):204-9. PubMed ID: 18507275
    [Abstract] [Full Text] [Related]

  • 10. Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy.
    Stergiou GS, Makris T, Papavasiliou M, Efstathiou S, Manolis A.
    J Hypertens; 2005 Apr 01; 23(4):883-9. PubMed ID: 15775795
    [Abstract] [Full Text] [Related]

  • 11. Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents.
    Gerbino PP, Shoheiber O.
    Am J Health Syst Pharm; 2007 Jun 01; 64(12):1279-83. PubMed ID: 17563050
    [Abstract] [Full Text] [Related]

  • 12. Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
    Chrysant SG, Bakris GL.
    Am J Hypertens; 2004 Jul 01; 17(7):590-6. PubMed ID: 15233978
    [Abstract] [Full Text] [Related]

  • 13. [One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients].
    Simonyi G, Ferenci T, Finta E, Igaz I, Balogh S, Gasparics R, Medvegy M.
    Orv Hetil; 2019 Mar 01; 160(9):343-348. PubMed ID: 30798621
    [Abstract] [Full Text] [Related]

  • 14. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O, Andrews LM, Wang L, Xie L.
    J Med Econ; 2011 Mar 01; 14(5):576-83. PubMed ID: 21728914
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Caro JJ, Lee K.
    Curr Hypertens Rep; 2002 Dec 01; 4(6):417-8. PubMed ID: 12419166
    [No Abstract] [Full Text] [Related]

  • 16. Combined therapy with benazepril and amlodipine in the treatment of hypertension inadequately controlled by an ACE inhibitor alone.
    Fogari R, Corea L, Cardoni O, Cosmi F, Porcellati C, Innocenti P, Provvidenza M, Timio M, Bentivoglio M, Bertocchi F, Zoppi A.
    J Cardiovasc Pharmacol; 1997 Oct 01; 30(4):497-503. PubMed ID: 9335410
    [Abstract] [Full Text] [Related]

  • 17. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
    Fan CM, Yan LR, Tao YK, Wang L, Li YQ, Gao MM, Wang YN, Li CX, Wang XW, Lu XL, Pang HM, Li YS.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan 01; 39(1):57-60. PubMed ID: 21418799
    [Abstract] [Full Text] [Related]

  • 18. Effect of antihypertensive monotherapy and combination therapy on arterial distensibility and left ventricular mass.
    Neutel JM, Smith DH, Weber MA.
    Am J Hypertens; 2004 Jan 01; 17(1):37-42. PubMed ID: 14700510
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
    Lee IT, Hung YJ, Chen JF, Wang CY, Lee WJ, Sheu WH.
    Clin Ther; 2012 Aug 01; 34(8):1735-50. PubMed ID: 22784975
    [Abstract] [Full Text] [Related]

  • 20. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
    Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ, ACCOMPLISH Trial Investigators.
    N Engl J Med; 2008 Dec 04; 359(23):2417-28. PubMed ID: 19052124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.